Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The sellers on social media claimed the product had been manufactured by a company called MD Pharma, ANMAT found
Vemlidy secured approval in 2016 in adults with chronic HBV infection with compensated liver disease and, in 2022, was expanded for treating chronic HBV infection in patients 12 and older
For those who had to stop the medication because it was considered too intolerable for them to continue was 2.9%
While these drugs arent typically known for causing liver problems, its still a good idea to keep an eye on things, especially if you have any existing liver conditions
US$ 21.90
US$ 27.36
US$ 22.77
US$ 21.98
US$ 29.82
US$ 29.47
